Advocacy intelligence hub — real-time data for patient organizations
Istituto Ortopedico Rizzoli — NA
Clinical Center of Vojvodina — PHASE4
Britecyte — PHASE1, PHASE2
Wuxi Cellular Biopharmaceutical Group Ltd. — PHASE3
Rigshospitalet, Denmark — PHASE1, PHASE2
Caliway Biopharmaceuticals Co., Ltd. — PHASE2
Syntr Health Technologies, Inc. — NA
University Hospital of North Norway — PHASE2, PHASE3
Centre Hospitalier Universitaire de Nice — NA
Lipogems International spa — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs